Journal of Virology, February 2004, p. 1971-1980, Vol. 78, No. 4
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.4.1971-1980.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Large-Scale Identification of Disease Genes Involved in Acute Myeloid Leukemia
Stefan J. Erkeland, Marijke Valkhof, Claudia Heijmans-Antonissen, Antoinette van Hoven-Beijen, Ruud Delwel, Mirjam H. A. Hermans, and Ivo P. Touw*
Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
Received 7 July 2003/
Accepted 27 October 2003
Acute myeloid leukemia (AML) is a heterogeneous group of diseases in which chromosomal aberrations, small insertions or deletions, or point mutations in certain genes have profound consequences for prognosis. However, the majority of AML patients present without currently known genetic defects. Retroviral insertion mutagenesis in mice has become a powerful tool for identifying new disease genes involved in the pathogenesis of leukemia and lymphoma. Here we have used the Graffi-1.4 strain of murine leukemia virus, which causes predominantly AML, in a screen to identify novel genes involved in the pathogenesis of this disease. We report 79 candidate disease genes in common integration sites (CISs) and 15 genes whose family members previously were found to be affected in other studies. The majority of the identified sequences (60%) were not found in lymphomas and monocytic leukemias in previous screens, suggesting a specific involvement in AML. Although most of the virus integrations occurred in or near the 5' or 3' ends of the genes, suggesting deregulation of gene expression as a consequence of virus integration, 18 CISs were located exclusively within the genes, conceivably causing gene disruption.
* Corresponding author. Mailing address: Department of Hematology, Erasmus University Medical Center, Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: 31-10-4087837. Fax: 31-10-4089470. E-mail: i.touw{at}erasmusmc.nl.
Journal of Virology, February 2004, p. 1971-1980, Vol. 78, No. 4
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.4.1971-1980.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hasemann, M. S., Damgaard, I., Schuster, M. B., Theilgaard-Monch, K., Sorensen, A. B., Mrsic, A., Krugers, T., Ylstra, B., Pedersen, F. S., Nerlov, C., Porse, B. T.
(2008). Mutation of C/EBP{alpha} predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen. Blood
111: 4309-4321
[Abstract]
[Full Text]
-
Voisin, V., Barat, C., Hoang, T., Rassart, E.
(2006). Novel insights into the pathogenesis of the graffi murine leukemia retrovirus.. J. Virol.
80: 4026-4037
[Abstract]
[Full Text]
-
Erkeland, S. J., Verhaak, R. G.W., Valk, P. J.M., Delwel, R., Lowenberg, B., Touw, I. P.
(2006). Significance of Murine Retroviral Mutagenesis for Identification of Disease Genes in Human Acute Myeloid Leukemia. Cancer Res.
66: 622-626
[Abstract]
[Full Text]
-
Lowther, W., Wiley, K., Smith, G. H., Callahan, R.
(2005). A New Common Integration Site, Int7, for the Mouse Mammary Tumor Virus in Mouse Mammary Tumors Identifies a Gene Whose Product Has Furin-Like and Thrombospondin-Like Sequences. J. Virol.
79: 10093-10096
[Abstract]
[Full Text]
-
van den Akker, E., Vankan-Berkhoudt, Y., Valk, P. J. M., Lowenberg, B., Delwel, R.
(2005). The Common Viral Insertion Site Evi12 Is Located in the 5'-Noncoding Region of Gnn, a Novel Gene with Enhanced Expression in Two Subclasses of Human Acute Myeloid Leukemia. J. Virol.
79: 5249-5258
[Abstract]
[Full Text]
-
Nielsen, A. A., Sorensen, A. B., Schmidt, J., Pedersen, F. S.
(2005). Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair. J. Virol.
79: 67-78
[Abstract]
[Full Text]
-
Delwel, H. R., Erpelinck, C., Verhaak, R., Touw, I. P., Lowenberg, B., Valk, P. J.M.
(2004). A Novel Subgroup of Poor Prognostic AML with Low CEBPA Expression, CEBPA Promoter Hypermethylation and DNMT3b Overexpression.. ASH ANNUAL MEETING ABSTRACTS
104: 418-418
[Abstract]
-
van de Geijn, G.-J. M., Gits, J., Touw, I. P.
(2004). Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J. Leukoc. Biol.
76: 237-244
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.